The Finnish startup Algorithmiq establishes new cooperation with IBM focused on leveraging the power of quantum computing for drug discovery and development.
On average, it currently takes around a decade and US$1 billion for a new drug to get to market. Algorithmiq's advances in this area are considered to reduce the time-to-market of new drugs significantly, and allow for more cost efficiency and better medical treatments.